Risk factors for antibiotic resistance in Streptococcus pneumoniae

K P Klugman1

  • 1Rollins School of Public Health, Emory University, Atlanta, USA. keith.klugman@emory.edu

Insights

Streptococcus pneumoniae infections are a major cause of preventable death. Antimicrobial resistance complicates treatment, necessitating strategies like conjugate pneumococcal vaccines, though resistance is increasing in non-vaccine types.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Vaccinology

Background:

  • Streptococcus pneumoniae (pneumococcus) is a primary cause of vaccine-preventable mortality in pediatric and adult populations.
  • The efficacy of managing pneumococcal infections is increasingly challenged by the emergence of antimicrobial resistance.
  • Identifying risk factors associated with resistance is crucial for effective public health interventions.

Purpose of the Study:

  • To summarize the key factors contributing to antimicrobial resistance in Streptococcus pneumoniae.
  • To highlight the role of conjugate pneumococcal vaccines in combating resistant strains.
  • To underscore the emerging challenge of resistance in non-vaccine serotypes.

Main Methods:

  • Literature review of studies on Streptococcus pneumoniae resistance patterns.
  • Analysis of identified risk factors for antimicrobial resistance.
  • Evaluation of the impact of conjugate pneumococcal vaccines on resistance.

Main Results:

  • Young age, hospitalization, daycare, antibiotic exposure, and HIV infection are significant risk factors for pneumococcal resistance.
  • Conjugate pneumococcal vaccines provide protection against resistant strains within vaccine serotypes.
  • A concerning trend of increasing antimicrobial resistance is observed in non-vaccine serotypes.

Conclusions:

  • Antimicrobial resistance in Streptococcus pneumoniae poses a significant threat to public health, particularly in vulnerable populations.
  • While conjugate vaccines are effective against vaccine serotypes, ongoing surveillance and development are needed to address resistance in non-vaccine types.
  • Comprehensive strategies encompassing vaccination and judicious antibiotic use are essential for controlling pneumococcal infections and resistance.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Antibiotic Selection00:57

Antibiotic Selection

Overview